Mexico: Merck cuts price of AIDS drug

Get RSS feed of these results

All components of this story

Article
+ Español - Hide

Author: Business Wire

AIDS Healthcare Foundation (AHF)…elogió a Merck & Company (conocida como Merck, Sharp & Dohme en México) por las reducciones en los precios de sus dos medicamentos clave contra el SIDA en México…Merck redujo el precio de su Stocrin…en un 40%...y de Isentress…en un 30%...Michael Weinstein, Presidente de AIDS Healthcare Foundation [afirmó que] “Si bien queda mucho por hacer en la lucha por lograr medicamentos accesibles contra el SIDA que preservan la vida en México y en todo el mundo…elogiamos a Merck hoy por establecer estas reducciones de precios de dos dígitos en respuesta a las solicitudes de los activistas…”

Read the full post here

Article
1 August 2008

Merck announces significant price cut to its AIDS drugs, Stocrin and Isentress

Author: AIDS Healthcare Foundation

AIDS Healthcare Foundation…commended Merck…over price cuts on two of its key AIDS drugs in Mexico... Merck cut its price of Stocrin…in Mexico by 40%...and on Isentress…by 30%... [According to] Michael Weinstein, AIDS Healthcare Foundation President…“Though there is still much to be done in the fight for affordable lifesaving AIDS drugs in Mexico and throughout the world…we commend Merck today for instituting these double digit price reductions in response to activists’ pleas for lower prices…”

 

Read the full post here